1. |
Roy VK, Kumar A, Joshi P, et al. Plasma free fatty acid concentrations as a marker for acute myocardial infarction[J]. J Clin Diagn Res, 2013, 7(11):2432-2434.
|
2. |
Pilz S, Scharnagl H, Tiran B, et al. Elevated plasma free fatty acids predict sudden cardiac death:a 6.85-year follow-up of 3315 patients aftercoronary angiography[J]. Eur Heart J, 2007, 28(22):2763-2769.
|
3. |
Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal definition of myocardial infarction[J]. Eur Heart J, 2012, 33(20):2551-2567.
|
4. |
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J, 2012, 33(20):2569-2619.
|
5. |
American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, O'gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American college of cardiology foundation/American heart association task force on practice guidelines[J]. J Am Coll Cardiol, 2013, 61(4):e78-e140.
|
6. |
Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2014, 130(25):e344-e426.
|
7. |
Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Rev Esp Cardiol, 2015, 68(12):1125.
|
8. |
王吉耀.内科学[M]. 2版.北京:人民卫生出版社, 2010:294-301.
|
9. |
Steinberg HO, Paradisi G, Hook G, et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production[J]. Diabetes, 2000, 49(7):1231-1238.
|
10. |
Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome:prospective multinational observational study (GRACE)[J]. BMJ, 2006, 333(7578):1091.
|
11. |
Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias[J]. Lancet, 1994, 343(8890):155-158.
|
12. |
Pilz S, Scharnagl H, Tiran B, et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease[J]. Atheroscler Suppl, 2006, 7(3):72.
|
13. |
霍娟, 傅汉菁.血清游离脂肪酸与胰岛β细胞功能及胰岛素抵抗[J].华西医学, 2010, 25(7):1255-1258.
|
14. |
王煜, 李秀钧, 邬云, 等.二甲双胍对糖脂中毒的大鼠胰岛β细胞胰岛素分泌功能的保护作用[J].华西医学, 2009, 24(4):920-922.
|
15. |
Giedd KN, Bergmann SR. Fatty acid imaging of the heart[J]. Curr Cardiol Rep, 2011, 13(2):121-131.
|
16. |
Schauer IE, Snell-Bergeon JK, Bergman BC, et al. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes:the CACTI study[J]. Diabetes, 2011, 60(1):306-314.
|
17. |
Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats:implications for human obesity[J]. Proc Natl Acad Sci USA, 2000, 97(4):1784-1789.
|
18. |
Oliver MF. Sudden cardiac death:the lost fatty acid hypothesis[J]. QJM, 2006, 99(10):701-709.
|
19. |
Zhou Z, Liu Y, Miao AD, et al. Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells[J]. Eur J Pharmacol, 2005, 513(1/2):1-8.
|
20. |
Karakas SE, Almario RU, Kim K. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers[J]. Metabolism, 2009, 58(7):1002-1007.
|